| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : Publications 2003 | published Mon, Nov 10, 2008 - 15:27 EST |
PUBLICATIONS:
Ambrose PG, Bhavnani SM, Jones RN. Pharmacokinetics/Pharmacodynamics of cefepime and piperacillin-tazobactam against E. coli and K. pneumoniae producing extended-spectrum beta-lactamase: (Report from the ARREST Program). Antimicrob Agents Chemother. 2003; 47:1643-46.
Jones RN, Rubino CM, Bhavnani SM, Ambrose PG. Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: Report from the Antimicrobial Resistance Rate Epidemiology Study Team. Antimicrob Agents Chemother. 2003; 47:292-96.
Ambrose PG, Bhavnani SM, Cirincione BB, Piedmonte M, Grasela TH. Pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction. Gatifloxacin and the elderly. J Antimicrob Chemother. 2003; 52:435-40.
Fetterly GJ, Straubinger RM. Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmSci. 2003;5:1-12.
Bhavnani SM, Hammel JP, Forrest A, Jones RN, Ambrose PG. Relationships between patient- and institution-specific variables and decreased susceptibility of gram-negative pathogens. Clin Infect Dis. 2003;37:344-50.
Ambrose PG, Bhavnani SM, Owens RC. Clinical pharmacodynamics of quinolones. Infect Dis Clin N Amer. 2003;529-43.
Nader ND, Walawander CA, TH Grasela. Statistics for the anesthesiologist. In, Practice of Anesthesia. 7th Edition, T Healy and PR Knight Arnold Publishers, London UK, 2003 pgs 69-82.
Bhavnani SM, Hammel JP, Forrest A, Jones RN, Ambrose PG. Integration of Patient- and Institution-Specific Variables Associated with Decreased In Vitro Susceptibility of Gram-Negative Pathogens: Application of Clinical Trial Design. Clinical Infectious Diseases 2003;37:344-350.
Ambrose PG, Bhavnani SM, Cirincione BB, Piedmonte M, Grasela TH. Gatifloxacin And The Elderly: Pharmacokinetic-Pharmacodynamic Rationale For A Potential Age-Related Dose Reduction. 2003;52(3):436-40.
Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, Fallat RJ, Stoller JK, Crystal RG, Turino GM. Asthma Features In Severe Alpha1-Antitrypsin Deficiency: Experience Of The National Heart, Lung, And Blood Institute Registry. 2003;123(3):765-71.
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2003 : Publications 2003 | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |